Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children

Gerhard K Wolf1, Craig D McClain, David Zurakowski

  • 1Children's Hospital, Boston, MA, USA.

Insights

Total phenytoin levels are unreliable for guiding treatment in critically ill children. Free phenytoin levels should be monitored to prevent toxicity and ensure effective dosing, as standard calculations are inaccurate.

Area of Science:

  • Pediatric Critical Care Medicine
  • Clinical Pharmacology
  • Neuropharmacology

Background:

  • Phenytoin is a crucial antiepileptic drug used in pediatric intensive care units.
  • Accurate therapeutic drug monitoring is essential for optimizing phenytoin efficacy and minimizing toxicity.
  • Variability in protein binding can significantly impact phenytoin pharmacokinetics, especially in critically ill populations.

Purpose of the Study:

  • To evaluate the correlation between measured free and total phenytoin levels in critically ill pediatric patients.
  • To assess the accuracy of the Sheiner-Tozer equation for estimating free phenytoin concentrations in this population.
  • To identify factors, including comedications, that influence phenytoin binding and therapeutic management.

Main Methods:

  • Retrospective chart review of 60 critically ill pediatric patients.
  • Analysis of phenytoin levels (total and free) and serum albumin concentrations.
  • Evaluation of the Sheiner-Tozer equation's predictive performance.
  • Identification of concurrent medications impacting phenytoin levels.

Main Results:

  • A moderate linear correlation (r = .795) was observed between free and total phenytoin concentrations.
  • The Sheiner-Tozer equation showed a significant mean difference (-0.31 ± 0.5 μg/mL) between estimated and measured free phenytoin levels.
  • Ten percent of patients exhibited toxic free phenytoin levels despite therapeutic total levels.
  • Elevated free fractions were noted in patients with low serum albumin (<2.5 g/dL) and those receiving valproic acid or cefazolin.

Conclusions:

  • Measured total phenytoin concentrations are unreliable for therapeutic drug monitoring in critically ill children.
  • Phenytoin binding exhibits greater variability in pediatric intensive care patients compared to adults, influenced by factors like hypoalbuminemia and comedications.
  • Routine measurement of free phenytoin concentrations is recommended for safe and effective dosing in this vulnerable population.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...